Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues

Progesterone antagonist RU486 (mifepristone) has been implicated for many anti-neoplastic and obstetrical applications. But the compound has demonstrated undesired agonist-like effect depending on cell, tissue and species studied. Using PR-transfected breast cancer cells MDA-MB-231, this report desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, V C-L, Aw, S E, Ng, E H, Ng, E H-L, Tan, M G-K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364017/
https://www.ncbi.nlm.nih.gov/pubmed/11747343
http://dx.doi.org/10.1054/bjoc.2001.2167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364017/
https://www.ncbi.nlm.nih.gov/pubmed/11747343
http://dx.doi.org/10.1054/bjoc.2001.2167

Ejemplares similares